Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed

The Food and Drug Administration (FDA) is seeking applicants for a cooperative agreement to support research related to analgesics, anesthetics, and addiction. The goal of this project is to develop, disseminate, implement, and evaluate research needed in anesthesia, addiction medicine, and pain medicine. The research should focus on areas such as clinical trial endpoints, outcome measures, and assessment of opioid clinical trials. Applicants must propose a comprehensive evidence-based plan that advances appropriate prescribing of drug products intended for analgesia, anesthesia, and substance use disorders. • The award ceiling is $2,000,000, and the award floor is $2,000,000. • Multiple awards may be considered. • The project should advance appropriate prescribing of drug products intended for analgesia, anesthesia, and substance use disorders. • The research should focus on areas such as clinical trial endpoints, outcome measures, and assessment of opioid clinical trials. • Applicants must propose a comprehensive evidence-based plan.